The News and Observer highlights some of the state's biggest startup successes of 2025, including Duke Engineering startups focused on genetic health solutions and bespoke 3D-printed orthopedic implants.
Duke researchers show how Dynamic Optical Contrast Imaging can help surgeons identify cancerous tissue during surgery to remove tumors.
Amanda Randles is working to develop a vascular digital twin model that might see a heart problem before a patient shows any symptoms.
Jessilyn Dunn explains why there is concern over population-wide data gathering plans from wearable devices and what could be done to protect individual privacy.
Nenad Bursac joins a radio news program to talk about his new study showing how a gene therapy his lab designed restores heart functionality in nonhuman primate models after a heart attack.
Charles Gersbach is one of many researchers working on the targeted rewriting of the epigenome, which promises to overcome several challenges in direct gene editing in patient therapies.
Charles Gersbach weighs in on the challenge of manufacturing gene therapies at large scales.
Charles Gersbach addressed leaders of the FDA in a roundtable with other leaders from the world of cell and gene therapy, discussing the potential of genome and epigenome editing.
Biomedical researchers at Duke University have developed a computational imaging system that borrows techniques from astronomy to reconstruct 4D videos of freely moving small model organisms, like zebrafish and fruit fly larvae.
Sparked by the efforts of parents with a child diagnosed with Alexander disease, Pranam Chatterjee is using his lab's technology to try to find a treatment or cure.
Researchers transformed a plant pathogen weapon into a programmable tool for DNA editing.
Naturally suppressed genes turned on by Professor Charles Gersbach lab's CRISPR technology offer cure hopes for rare diseases.
